Comment on Rooney et al. Global Prevalence of Prediabetes. Diabetes Care 2023;46:1388–1394prediabetesThe article highlights the global prevalence of prediabetes, highlighting the emergence of impaired fasting glucose (IFG) as a considerable concern. It also discusses on the burden, ri...
We aim to estimate the burden of diabetes by type, year, regions, and socioeconomic status in 195 countries and territories over the past 28 years, which provide information to achieve the goal of World Health Organization Global Action Plan for the Prevention and Control of Noncommunicable Diseas...
2023, The Lancet Citation Excerpt : We use key literature and narrative synthesis to discuss in more depth how downstream social determinants of health affect clinical diabetes outcomes (figure 3). Public awareness of the global burden of diabetes is tantamount to developing policy that supports eff...
The global burden of diabetes and its complications: an emerging pandemic. Eur. J. Cardiovasc. Prev. Rehabil. 17, S3–S8 (2010). PubMed Google Scholar Afkarian, M. et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014. JAMA 316, 602–610 (2016)....
have suggested those with diabetes have a significantly greater risk of severe disease outcomes. The current large global burden of disease due to both COVID-19 and diabetes is likely to be a significant public health concern worldwide, making it crucial to quantify the impact of diabetes on th...
GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.Lancet402, 203–234 (2023).
Measuring the global burden of diabetes: implications for health policy, practice, and research The Lancet, Volume 402, Issue 10397, 15–21 July 2023, Pages 163-165 David A Watkins, Mohammed K Ali Diabetes: a defining disease of the 21st century The Lancet, Volume 401, Issue 10394, 24–30...
This year marked the launch of the Global Burden of Disease (GBD) 2021 study, the first presentation of the study to incorporate the devastating direct, and indirect, worldwide impacts from the COVID-19 pandemic on population health. Understanding how the study differs from its predecessors is ...
The global burden of diabetes and hypertension will continue to rise as the population ages and life expectancy increases, with a corresponding increase in the burden of CKD [18]. Decomposition analysis revealed that population growth and aging contributed 50.82% and 37.48%, respectively, to the in...
The aim of global ophthalmology is to maximize vision, ocular health and functional ability, thereby contributing to overall health and well-being, social inclusion and quality of life of every individual worldwide. Currently, an estimated 1.1 billion people live with visual impairment, 90% of whic...